We are live on
!
Find out more
Lexeo Therapeutics
LXEO
LXEO
139 hedge funds and large institutions have $459M invested in Lexeo Therapeutics in 2026 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 58 increasing their positions, 38 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
548% more call options, than puts
Call options by funds: $389K | Put options by funds: $60K
53% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 38
4.7% more ownership
Funds ownership: 104.76% → 109.46% (+4.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less funds holding
Funds holding: 146 → 139 (-7)
22% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 27
40% less capital invested
Capital invested by funds: $759M → $459M (-$300M)
Holders
139
Holders Change
-7
Holders Change %
-4.79%
% of All Funds
1.71%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
21
Increased
58
Reduced
38
Closed
27
Calls
$389K
Puts
$60K
Net Calls
+$329K
Net Calls Change
+$336K
Top Buyers
| 1 |
AAA
Affinity Asset Advisors
New York
|
+$13.1M |
| 2 |
O
OrbiMed
New York
|
+$10.5M |
| 3 |
PBA
Paradigm Biocapital Advisors
New York
|
+$10.1M |
| 4 |
Goldman Sachs
New York
|
+$8.28M |
| 5 |
SSC
Spruce Street Capital
New York
|
+$5.34M |
Top Sellers
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$10.1M |
| 2 |
SL
Siren LLC
Greenwich,
Connecticut
|
-$7.16M |
| 3 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$6.13M |
| 4 |
OCA
Octagon Capital Advisors
New York
|
-$4.43M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$4.25M |
